CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disorders

Qinhong Xu1, Jieni Yu1, Xiaoyan Lin2

  • 1Department of Hematology, Zhongshan Hospital, Xiamen University, Fujian Medical University Clinic Teaching Hospital, Xiamen, Fujian, China.

Medicine
|December 29, 2021
PubMed
Abstract

Insights

This case report details a rare instance of four simultaneous blood disorders in one patient: T-LGLL, MGUS, CB-LPD, and PRCA. Treatment led to transfusion independence, offering a clinical reference for these co-occurring conditions.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic plasma cell disorder.
  • Pure red cell aplasia (PRCA) and T-large granular lymphocyte leukemia (T-LGLL) are rare hematological conditions.
  • Co-occurrence of T-LGLL with MGUS and clonal B-cell lymphoproliferative disorders (CB-LPD) is exceptionally rare.

Observation:

  • A 77-year-old male presented with anemia and was diagnosed with MGUS, CB-LPD, and PRCA.
  • Flow cytometry revealed abnormal T lymphocytes, leading to a T-LGLL diagnosis.
  • The patient exhibited four concomitant hematological disorders.

Findings:

  • Diagnosis was confirmed through clinical presentation, T cell receptor gene rearrangement, and immunophenotype.
  • Treatment involved bortezomib, dexamethasone, Rituximab, and sirolimus.
  • The patient achieved transfusion independence post-therapy.

Implications:

  • This case highlights the clinical and flow cytometry characteristics of coexisting T-LGLL, MGUS, CB-LPD, and PRCA.
  • Understanding the mechanisms underlying these combined disorders is crucial.
  • This report serves as a valuable clinical reference for managing similar complex hematological cases.